Skip to content

New Mechanisms of Obesity

Pathogenic Mechanisms of Obesity and Its Cardiometabolic Complications

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06768827
Acronym
NMoO
Enrollment
55
Registered
2025-01-10
Start date
2025-11-13
Completion date
2030-03-31
Last updated
2026-01-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insulin Resistance, Obesity and Obesity-related Medical Conditions, Obesity and Overweight

Keywords

Obesity, Youth, Insulin Resistance, Intestinal Fermentation

Brief summary

Given the pervasiveness of Pediatric Obesity, it is imperative to understand its pathophysiology and develop alternative strategies to reverse this condition. Herein, investigators propose to elucidate the interaction between colonic fermentation and insulin resistance in modulating metabolism in youth with obesity.

Detailed description

Pediatric obesity is a major health burden affecting millions of children and adolescents as it predisposes to the development of cardio-metabolic diseases early in life, such as insulin resistance, fatty liver disease and type 2 diabetes. Investigators have recently completed a series of studies to understand the relationship between the intestinal microbial activity and human metabolism in youth. It was observed that intestinal fermentation, a process through which fermentable carbohydrates are processed by intestinal bacteria, results in a variety of biological responses aimed at protecting the human body from developing obesity and some of its metabolic complications, such as insulin resistance and ectopic fat accumulation. In particular, investigators observed that intestinal fermentation causes 1- a reduction of plasma free fatty acids (FFA), due to the inhibition of adipose tissue lipolysis (ATL); 2- a marked entero-endocrine response to reduce appetite, characterized by an increase in the production of peptide YY (PYY) and glucagon-like peptide1 (GLP-1) and a reduced production of ghrelin. In addition, investigators observed that some intestinal fermentation responses are impaired in youth with obesity and insulin resistance (OIR). In light of this evidence, the current proposal will address: 1- how adipose tissue lipolysis response to intestinal fermentation is affected by insulin resistance; 2- whether changes in ATL, observed when fermentation occurs, are also associated with a reduction of glycerol derived neo-gluconeogenesis; 3- if physical activity may restore the entero-endocrine and adipose tissue response to intestinal fermentation in youth with insulin resistance. This is the first study to test the effect of insulin resistance on the relationship between intestinal microbial metabolic activity and human metabolism (namely adipose tissue lipolysis, gluconeogenesis and entero-endocrine response). The results obtained will provide fundamental insight into how insulin resistance occurring in youth with obesity affects the metabolic response to fermentable carbohydrates. In fact, despite the large body of literature showing an association between intestinal microbial fermentation and human metabolism, how and whether insulin resistance may modulate this association remains unknown.

Interventions

Each arm will undergo a study to induce colonic fermentation through lactulose at the beginning and at the end of the 12 weeks.

Sponsors

Yale University
Lead SponsorOTHER
National Institutes of Health (NIH)
CollaboratorNIH
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
15 Years to 22 Years
Healthy volunteers
No

Inclusion criteria

* Age 15 to 22 years * In puberty (girls and boys: Tanner stage III-V); * BMI \>85th

Exclusion criteria

* Pregnancy; * endocrinopathies (e.g., Cushing syndrome); * substance abuse; * medications affecting insulin resistance such as metformin, GLP-1 analogues; - * high fibers intake (\> 30g/day) as assessed by a 3-day food record.

Design outcomes

Primary

MeasureTime frameDescription
CHANGES IN ADIPOSE TISSUE LIPOLYSIS (ATL)6 hoursChanges in adipose tissue lipolysis occurring after colonic fermentation (stimulated by lactulose) will be compared between youth with obesity and insulin resistance (OIR) and with obesity and without insulin resistance (OIS). Lipolysis will be measured by using change in D5-glycerol concentration.
CHANGES IN GLUCONEOGENESIS6 hoursGluconeogenesis (GLC) will be measured using change in deuterium oxide concentration after colonic fermentation due to lactulose ingestion and compared between OIS and OIR.

Secondary

MeasureTime frameDescription
CHANGES IN PEPTIDE YY (PYY) concentrationBaseline and 12 weeksChanges in PYY concentration after lactulose intervention will be compared between OIS and OIR.
CHANGES IN GHRELIN concentrationBaseline and 12 weeksChanges in GHRELIN concentration after lactulose intervention will be compared between OIS and OIR.

Countries

United States

Contacts

CONTACTNICOLA SANTORO, MD, PhD
nicola.santoro@yale.edu2037852819
PRINCIPAL_INVESTIGATORNICOLA SANTORO, MD, PhD

Yale University

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026